Trial Profile
A retrospective study to evaluate antifungal prophylaxis regimens in patients with acute myeloid leukemia receiving induction chemotherapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Oct 2015
Price :
$35
*
At a glance
- Drugs Micafungin (Primary) ; Posaconazole (Primary)
- Indications Mycoses
- Focus Therapeutic Use
- 20 Oct 2015 New trial record
- 14 Sep 2015 Results published in Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy